Activation of NF- (cid:2) B by Human Papillomavirus 16 E1 Limits E1-Dependent Viral Replication through Degradation of E1

ABSTRACT NF-κB is a family of transcription factors that regulate gene expression involved in many processes, such as the inflammatory response and cancer progression. Little is known about associations of NF-κB with the human papillomavirus (HPV) life cycle. We have developed a tissue culture system to conditionally induce E1-dependent replication of the human papillomavirus 16 (HPV16) genome in human cervical keratinocytes and found that expression of HPV16 E1, a viral helicase, results in reduction of IκBα and subsequent activation of NF-κB in a manner dependent on helicase activity. Exogenous expression of a degradation-resistant mutant of IκBα, which inhibits the activation of NF-κB, enhanced E1-dependent replication of the viral genome. Wortmannin, a broad inhibitor of phosphoinositide 3-kinases (PI3Ks), and, to a lesser extent, VE-822, an ATR kinase inhibitor, but not KU55933, an ATM kinase inhibitor, suppressed the activation of NF-κB and augmented E1-dependent replication of the HPV16 genome. Interestingly, the enhancement of E1-dependent replication of the viral genome was associated with increased stability of E1 in the presence of wortmannin as well as the IκBα mutant. Collectively, we propose that expression of E1 induces NF-κB activation at least in part through the ATR-dependent DNA damage response and that NF-κB in turn limits E1-dependent replication of HPV16 through degradation of E1, so that E1 and NF-κB may constitute a negative feedback loop. IMPORTANCE A major risk factor in human papillomavirus (HPV)-associated cancers is persistent infection with high-risk HPVs. To eradicate viruses from infected tissue, it is important to understand molecular mechanisms underlying the establishment and maintenance of persistent infection. In this study, we obtained evidence that human papillomavirus 16 (HPV16) E1, a viral DNA helicase essential for amplification of the viral genomes, induces NF-κB activation and that this limits E1-dependent genome replication of HPV16. These results suggest that NF-κB mediates a negative feedback loop to regulate HPV replication and that this feedback loop could be associated with control of the viral copy numbers. We could thus show for the first time that NF-κB activity is involved in the establishment and maintenance of persistent HPV infection.

[1]  J. Archambault,et al.  The E1 proteins. , 2013, Virology.

[2]  Li'na Hu,et al.  Constitutive Activation of Nuclear Factor κB Contributes to Cystic Fibrosis Transmembrane Conductance Regulator Expression and Promotes Human Cervical Cancer Progression and Poor Prognosis , 2013, International Journal of Gynecologic Cancer.

[3]  S. H. van der Burg,et al.  Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response , 2013, PLoS pathogens.

[4]  L. Laimins,et al.  Human Papillomaviruses Modulate MicroRNA 145 Expression To Directly Control Genome Amplification , 2013, Journal of Virology.

[5]  J. Bashkin,et al.  Human Papillomavirus Episome Stability Is Reduced by Aphidicolin and Controlled by DNA Damage Response Pathways , 2013, Journal of Virology.

[6]  Y. Shiloh,et al.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. , 2013, Nature reviews. Molecular cell biology.

[7]  Wim Quint,et al.  The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.

[8]  M. Ustav,et al.  Engagement of the ATR-Dependent DNA Damage Response at the Human Papillomavirus 18 Replication Centers during the Initial Amplification , 2012, Journal of Virology.

[9]  Cary A Moody,et al.  Human Papillomaviruses Recruit Cellular DNA Repair and Homologous Recombination Factors to Viral Replication Centers , 2012, Journal of Virology.

[10]  M. Stanley Epithelial Cell Responses to Infection with Human Papillomavirus , 2012, Clinical Microbiology Reviews.

[11]  C. Woodworth,et al.  Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. , 2012, Virology.

[12]  M. Pasparakis Role of NF‐κB in epithelial biology , 2012, Immunological reviews.

[13]  Sankar Ghosh,et al.  NF-κB, the first quarter-century: remarkable progress and outstanding questions. , 2012, Genes & development.

[14]  N. Perkins,et al.  The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.

[15]  G. Peters,et al.  DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. , 2012, Molecular cell.

[16]  M. Fujita,et al.  The E1 Protein of Human Papillomavirus Type 16 Is Dispensable for Maintenance Replication of the Viral Genome , 2012, Journal of Virology.

[17]  N. Reich,et al.  The DNA Damage Response Induces IFN , 2011, The Journal of Immunology.

[18]  S. Boubaker,et al.  Keratinocyte sensitization to tumour necrosis factor-induced nuclear factor kappa B activation by the E2 regulatory protein of human papillomaviruses. , 2011, The Journal of general virology.

[19]  R. Mitra,et al.  The Papillomavirus E1 Helicase Activates a Cellular DNA Damage Response in Viral Replication Foci , 2011, Journal of Virology.

[20]  J. Archambault,et al.  Nuclear Accumulation of the Papillomavirus E1 Helicase Blocks S-Phase Progression and Triggers an ATM-Dependent DNA Damage Response , 2011, Journal of Virology.

[21]  土谷 佳弘 Nuclear IKKβ is an adaptor protein for IκBα ubiquitination and degradation in UV-induced NF-κB activation , 2011 .

[22]  E. Cesarman,et al.  NF-κB as a target for oncogenic viruses. , 2011, Current topics in microbiology and immunology.

[23]  S. Miyamoto Nuclear initiated NF-κB signaling: NEMO and ATM take center stage , 2011, Cell Research.

[24]  Alexander Hoffmann,et al.  A single NFκB system for both canonical and non-canonical signaling , 2011, Cell Research.

[25]  M. Donaldson,et al.  Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. , 2010, Virology.

[26]  G. Sen,et al.  The Inhibitory Action of P56 on Select Functions of E1 Mediates Interferon's Effect on Human Papillomavirus DNA Replication , 2010, Journal of Virology.

[27]  M. Karin,et al.  Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation. , 2010, Molecular cell.

[28]  C. Grandori,et al.  NFX1 Plays a Role in Human Papillomavirus Type 16 E6 Activation of NFκB Activity , 2010, Journal of Virology.

[29]  C. Hagemeier,et al.  p53- and p21-dependent premature APC/C–Cdh1 activation in G2 is part of the long-term response to genotoxic stress , 2010, Oncogene.

[30]  S. Yoshida,et al.  Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokines , 2010, Cancer science.

[31]  P. Heisig Type II topoisomerases--inhibitors, repair mechanisms and mutations. , 2009, Mutagenesis.

[32]  Cary A Moody,et al.  Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation , 2009, PLoS pathogens.

[33]  D. Cortez,et al.  Common mechanisms of PIKK regulation. , 2009, DNA repair.

[34]  Zhuohua Zhang,et al.  Detection of protein ubiquitination. , 2009, Journal of visualized experiments : JoVE.

[35]  R. Roden,et al.  Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions , 2009, Journal of Virology.

[36]  Li'na Hu,et al.  Association of Constitutive Nuclear Factor-&kgr;B Activation With Aggressive Aspects and Poor Prognosis in Cervical Cancer , 2009, International Journal of Gynecologic Cancer.

[37]  M. Ustav,et al.  Papillomavirus DNA replication - from initiation to genomic instability. , 2009, Virology.

[38]  G. Sen,et al.  Interferon‐inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1 , 2008, The EMBO journal.

[39]  E. Srivatsan,et al.  Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. , 2008, Cancer cell.

[40]  J. Archambault,et al.  Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification , 2007, Proceedings of the National Academy of Sciences.

[41]  A. Nussenzweig,et al.  The NBS1-ATM Connection Revisited , 2007, Cell cycle.

[42]  M. Fujita,et al.  HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes , 2007, Oncogene.

[43]  M. Fujita,et al.  Regulation of Notch1 Gene Expression by p53 in Epithelial Cells , 2007, Molecular and Cellular Biology.

[44]  David J. Chen,et al.  Ataxia Telangiectasia Mutated (ATM) Is Essential for DNA-PKcs Phosphorylations at the Thr-2609 Cluster upon DNA Double Strand Break* , 2007, Journal of Biological Chemistry.

[45]  P. Nair,et al.  Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. , 2007, Gynecologic oncology.

[46]  A. Klingelhutz,et al.  Human Papillomavirus Type 16 E6 Activates NF-κB, Induces cIAP-2 Expression, and Protects against Apoptosis in a PDZ Binding Motif-Dependent Manner , 2006, Journal of Virology.

[47]  P. Beard,et al.  Different Modes of Human Papillomavirus DNA Replication during Maintenance , 2006, Journal of Virology.

[48]  M. Stanley,et al.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Xuan Liu,et al.  Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis , 2005, Oncogene.

[50]  T. R. Broker,et al.  HPV-18 confers resistance to TNF-α in organotypic cultures of human keratinocytes , 2004 .

[51]  A. Castro,et al.  Bovine Papillomavirus Replicative Helicase E1 Is a Target of the Ubiquitin Ligase APC , 2004, Journal of Virology.

[52]  M. Welsh,et al.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  I. Verma,et al.  IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy , 2003, Molecular and Cellular Biology.

[54]  Yingnian Yu,et al.  ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. , 2003, Carcinogenesis.

[55]  A. Hoffmann,et al.  CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response , 2003 .

[56]  G. Chen,et al.  The Nuclear Localization of NFκB and p53 Is Positively Correlated with HPV16 E7 Level in Laryngeal Squamous Cell Carcinoma1 , 2003 .

[57]  D. Karunagaran,et al.  NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix , 2003, Oncogene.

[58]  O. Coux,et al.  Regulation of Bovine Papillomavirus Replicative Helicase E1 by the Ubiquitin-Proteasome Pathway , 2002, Journal of Virology.

[59]  G. Sen,et al.  Long-Term Effect of Interferon on Keratinocytes That Maintain Human Papillomavirus Type 31 , 2002, Journal of Virology.

[60]  D. McCance,et al.  Down Regulation of the Interleukin-8 Promoter by Human Papillomavirus Type 16 E6 and E7 through Effects on CREB Binding Protein/p300 and P/CAF , 2002, Journal of Virology.

[61]  T. Hofmann,et al.  The Human Papillomavirus Oncoprotein E7 Attenuates NF-κB Activation by Targeting the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.

[62]  P. Delvenne,et al.  Differential production of cytokines and activation of NF-kappaB in HPV-transformed keratinocytes. , 2002, Virology.

[63]  R. Wu,et al.  Increased p50/p50 NF-κB Activation in Human Papillomavirus Type 6- or Type 11-Induced Laryngeal Papilloma Tissue , 2002, Journal of Virology.

[64]  T. Hofmann,et al.  The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. , 2002, The Journal of biological chemistry.

[65]  M. Nakao,et al.  Activation of Cdh1‐dependent APC is required for G1 cell cycle arrest and DNA damage‐induced G2 checkpoint in vertebrate cells , 2001, The EMBO journal.

[66]  K. Makino,et al.  E1A inhibition of radiation-induced NF-κB activity through suppression of IKK activity and IκB degradation, independent of Akt activation , 2001 .

[67]  C. Woodworth,et al.  Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-κB-Responsive Genes in Cervical Keratinocytes , 2001, Journal of Virology.

[68]  J. de Graaf,et al.  A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. , 2000, Virology.

[69]  L. Laimins,et al.  Microarray Analysis Identifies Interferon-Inducible Genes and Stat-1 as Major Transcriptional Targets of Human Papillomavirus Type 31 , 2000, Journal of Virology.

[70]  G. Shaw,et al.  Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System , 1999, Journal of Virology.

[71]  H. Pahl,et al.  Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli. , 1995, The EMBO journal.

[72]  M. Hummel,et al.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes , 1992, Journal of Virology.

[73]  D. Lowy,et al.  Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.